医学
奥西默替尼
培美曲塞
卡铂
埃罗替尼
吉非替尼
肿瘤科
肺癌
内科学
表皮生长因子受体
T790米
贝伐单抗
腺癌
多西紫杉醇
化疗
癌症
顺铂
作者
Qiang Guo,Weiqiang Feng,Sheng Hu,Jiayue Ye,Silin Wang,Lang Su,Yang Zhang,Deyuan Zhang,Wenxiong Zhang,Jianjun Xu,Yiping Wei
出处
期刊:Medicine
[Wolters Kluwer]
日期:2023-08-25
卷期号:102 (34): e34545-e34545
被引量:2
标识
DOI:10.1097/md.0000000000034545
摘要
These cases suggest that osimertinib is a promising treatment option for patients with EGFR 19 deletion-mutated lung adenocarcinoma and bone metastases, although further clinical studies are needed to confirm its efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI